PCBL PCBL Chemical Q4 FY26 results (Jan–Mar 2026) and concall
PCBL Chemical navigated a challenging Q4 FY26 marked by geopolitical disruptions and cost pressures, yet showed signs of recovery with strong domestic volume growth and significant progress on strategic initiatives like capacity expansion and cost reduction. The company remains optimistic about FY27, targeting double-digit EBITDA growth and substantial improvements in Aquapharm's performance, while strengthening its balance sheet.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue down 1.0%, net profit down 60.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,163 | 2,010 | 2,087 | 2,114 | 2,164 +0% | 1,846 −8% | 2,066 −1% |
| EBITDA | 364 | 317 | 298 | 319 | 266 −27% | 215 −32% | 243 −18% |
| Net profit | 123 | 93 | 100 | 94 | 62 −50% | 2 −98% | 40 −60% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





